This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2016 Feb;13(2):77-8.

doi: 10.1038/nrclinonc.2015.237. Epub 2016 Jan 20.

Melanoma in 2015: Immune-checkpoint blockade - durable cancer control

Elizabeth I Buchbinder¹, F Stephen Hodi¹

Affiliations

PMID: 26787285
DOI: 10.1038/nrclinonc.2015.237

Melanoma in 2015: Immune-checkpoint blockade - durable cancer control

Elizabeth I Buchbinder et al. Nat Rev Clin Oncol. 2016 Feb.

. 2016 Feb;13(2):77-8.

doi: 10.1038/nrclinonc.2015.237. Epub 2016 Jan 20.

Authors

Elizabeth I Buchbinder¹, F Stephen Hodi¹

Affiliation

¹ Melanoma Disease Center, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215-05450, USA.

PMID: 26787285
DOI: 10.1038/nrclinonc.2015.237

No abstract available

PubMed Disclaimer

Similar articles

Therapeutic use of anti-CTLA-4 antibodies.
Blank CU, Enk A. Blank CU, et al. Int Immunol. 2015 Jan;27(1):3-10. doi: 10.1093/intimm/dxu076. Epub 2014 Jul 18. Int Immunol. 2015. PMID: 25038057 Review.
Combined anti-PD-1 and anti-CTLA-4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action.
Willsmore ZN, Coumbe BGT, Crescioli S, Reci S, Gupta A, Harris RJ, Chenoweth A, Chauhan J, Bax HJ, McCraw A, Cheung A, Osborn G, Hoffmann RM, Nakamura M, Laddach R, Geh JLC, MacKenzie-Ross A, Healy C, Tsoka S, Spicer JF, Josephs DH, Papa S, Lacy KE, Karagiannis SN. Willsmore ZN, et al. Eur J Immunol. 2021 Mar;51(3):544-556. doi: 10.1002/eji.202048747. Epub 2021 Feb 23. Eur J Immunol. 2021. PMID: 33450785 Review.
Immunotherapy and the concept of a clinical cure.
Eggermont AM, Kroemer G, Zitvogel L. Eggermont AM, et al. Eur J Cancer. 2013 Sep;49(14):2965-7. doi: 10.1016/j.ejca.2013.06.019. Epub 2013 Jul 25. Eur J Cancer. 2013. PMID: 23890942
CTLA-4 and PD-1/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients.
Ott PA, Hodi FS, Robert C. Ott PA, et al. Clin Cancer Res. 2013 Oct 1;19(19):5300-9. doi: 10.1158/1078-0432.CCR-13-0143. Clin Cancer Res. 2013. PMID: 24089443 Review.
The perspective of immunotherapy: new molecules and new mechanisms of action in immune modulation.
Blank CU. Blank CU. Curr Opin Oncol. 2014 Mar;26(2):204-14. doi: 10.1097/CCO.0000000000000054. Curr Opin Oncol. 2014. PMID: 24424272 Review.

See all similar articles

Cited by

Proteomics and melanoma: a current perspective.
Shields BD, Tackett AJ, Shalin SC. Shields BD, et al. Glob Dermatol. 2016 Aug;3(4):366-370. Epub 2016 Jun 20. Glob Dermatol. 2016. PMID: 30214824 Free PMC article.
Nanoparticle-based approaches to target the lymphatic system for antitumor treatment.
Peng X, Wang J, Zhou F, Liu Q, Zhang Z. Peng X, et al. Cell Mol Life Sci. 2021 Jun;78(12):5139-5161. doi: 10.1007/s00018-021-03842-6. Epub 2021 May 8. Cell Mol Life Sci. 2021. PMID: 33963442 Free PMC article. Review.
Bioresponsive and immunotherapeutic nanomaterials to remodel tumor microenvironment for enhanced immune checkpoint blockade.
Fang T, Cao X, Wang L, Chen M, Deng Y, Chen G. Fang T, et al. Bioact Mater. 2023 Nov 3;32:530-542. doi: 10.1016/j.bioactmat.2023.10.023. eCollection 2024 Feb. Bioact Mater. 2023. PMID: 38026439 Free PMC article.
Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions.
Ralli M, Botticelli A, Visconti IC, Angeletti D, Fiore M, Marchetti P, Lambiase A, de Vincentiis M, Greco A. Ralli M, et al. J Immunol Res. 2020 Jun 28;2020:9235638. doi: 10.1155/2020/9235638. eCollection 2020. J Immunol Res. 2020. PMID: 32671117 Free PMC article. Review.
Role of EZH2 histone methyltrasferase in melanoma progression and metastasis.
Mahmoud F, Shields B, Makhoul I, Hutchins LF, Shalin SC, Tackett AJ. Mahmoud F, et al. Cancer Biol Ther. 2016 Jun 2;17(6):579-91. doi: 10.1080/15384047.2016.1167291. Epub 2016 Apr 22. Cancer Biol Ther. 2016. PMID: 27105109 Free PMC article. Review.

See all "Cited by" articles

References

1. Nature. 2014 Nov 27;515(7528):563-7 - PubMed
1. Nature. 2015 Jul 9;523(7559):231-5 - PubMed
1. Science. 2015 Apr 3;348(6230):124-8 - PubMed
1. Cell. 2015 Jun 18;161(7):1681-96 - PubMed
1. N Engl J Med. 2010 Aug 19;363(8):711-23 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information